Rapha Capital Management logo

Rapha Capital Management

North America, New York, United States, Florida

Description

Rapha Capital Management is an investment company that invests in early stage biotechnology companies.

Investor Profile

Rapha Capital Management has made 8 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (50%)
  • Post Ipo Debt (25%)
  • Series C (13%)
  • Convertible Note (13%)

Country Focus

  • United States (75%)
  • Israel (25%)

Industry Focus

  • Health Care
  • Biotechnology
  • Therapeutics
  • Health Diagnostics
  • Medical Device
  • Pharmaceutical
  • Biopharma
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Rapha Capital Management frequently co-invest with?

B&
North America, New Jersey, United States, Mendham
Co-Investments: 2
PC
North America, Florida, United States, Naples
Co-Investments: 1
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Malin Corporation
Europe, Dublin, Ireland, Dublin
Co-Investments: 1
Longitude Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 3
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1
PC
North America, North Carolina, United States, Greensboro
Co-Investments: 1
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 1

What are some of recent deals done by Rapha Capital Management?

FIZE Medical

Modi'in, HaMerkaz, Israel

FIZE Medical is creating an AI-powered fluid management platform, for smart, personalized, and pro-active patient treatment.

Health CareMedical Device
Series ADec 24, 2024
Amount Raised: $14,000,000
AsclepiX Therapeutics

Baltimore, Maryland, United States

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Series AJul 26, 2023
Amount Raised: $10,000,000
Imagin Medical

Framingham, Massachusetts, United States

Imagin Medical is a surgical imaging company.

Health CarePharmaceutical
Post Ipo DebtAug 22, 2022
Amount Raised: $7,250,000
Imagin Medical

Framingham, Massachusetts, United States

Imagin Medical is a surgical imaging company.

Health CarePharmaceutical
Post Ipo DebtAug 30, 2021
Amount Raised: $3,000,000
FIZE Medical

Modi'in, HaMerkaz, Israel

FIZE Medical is creating an AI-powered fluid management platform, for smart, personalized, and pro-active patient treatment.

Health CareMedical Device
Series AApr 6, 2021
Amount Raised: $5,300,000
AsclepiX Therapeutics

Baltimore, Maryland, United States

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Series AJun 24, 2020
Amount Raised: $35,000,000
Poseida Therapeutics

San Diego, California, United States

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

BiopharmaBiotechnologyGeneticsTherapeutics
Series CApr 22, 2019
Amount Raised: $142,000,000
AsclepiX Therapeutics

Baltimore, Maryland, United States

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Convertible NoteNov 13, 2018
Amount Raised: $5,000,000